Barriers to screening and diagnosis of peripheral artery disease by general practitioners

Vascular Medicine (United Kingdom)

Volumn 18, Issue 6, 2013, Pages 325-330

  Haigh, Kate Jamilla ^a   Bingley, John ^b   Golledge, Jonathan ^c   Walker, Philip J ^d,e  

^a TOOWOOMBA HOSPITAL   (Australia)

^b Mater Adults Hospital   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

ankle brachial index; cardiovascular diseases; general practice; peripheral artery disease; peripheral vascular diseases; prevention; primary care; treatment

Indexed keywords

ANKLE BRACHIAL INDEX; ARTICLE; AUSTRALIA; DIAGNOSTIC TEST; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCREENING; ULTRASOUND;

ANKLE-BRACHIAL INDEX; CARDIOVASCULAR DISEASES; GENERAL PRACTICE; PERIPHERAL ARTERY DISEASE; PERIPHERAL VASCULAR DISEASES; PREVENTION; PRIMARY CARE; TREATMENT;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; AUSTRALIA; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; GENERAL PRACTITIONERS; HUMANS; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84889816939     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X13505673     Document Type: Article

References (20)

1. World Health Organization. Cardiovascular diseases (CVDs). Fact sheet no. 317; 2011 (last updated March 2013). Available from: www.who.int/mediacentre/ factsheets/fs317/en/index.html (accessed 29 August 2012).
2. Sabouret P, Cacoub P, Dallongeville J, et al. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis. 2008 ; 101: 81-88
3. Fowler B, Jamrozik K, Norman P, Allen Y. Prevalence of peripheral arterial disease: persistence of excess risk in former smokers. Aust N Z J Public Health. 2002 ; 26: 219-224
4. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009 ; 120: 2053-2061
5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 ; 45: S5-67
6. Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011 ; 124: 17-23
7. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996 ; 348: 1329-1339
8. Ostergren J, Sleight P, Dagenais G, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004 ; 25: 17-24
9. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007 ; 45: 645-654
10. Ferreira AC, Macedo FY. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management. Ann Med. 2010 ; 42: 139-150
11. Dachun X, Jue L, Liling Z, et al. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 2010 ; 15: 361-369
12. Rooke TW, Hirsch AT, Misra S, et al. ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011 2011 ; 58: 2020-2045
13. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 ; 286: 1317-1324
14. Cimminiello C, Kownator S, Wautrecht JC, et al. The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk. Intern Emerg Med. 2011 ; 6: 509-519
15. Mohler ER, Treat-Jacobson D, Reilly MP, et al. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med. 2004 ; 9: 253-260
16. Hayoz D, Bounameaux H, Canova CR. Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease. J Intern Med. 2005 ; 258: 238-243
17. Australian Government Department of Health and Aging. Measurement of ankle brachial indices and arterial waveform analysis. Commonwealth of Australia; 2011. Available from: http://www9.health.gov.au/mbs/fullDisplay.cfm? type=item&q=11610&qt=item&criteria= (accessed 6 June 2011).
18. Australian Government Department of Health and Aging. Duplex ultrasound. Commonwealth of Australia; 2011Available from: http://www9.health.gov.au/mbs/ fullDisplay.cfm?type=item&q=55238&qt=item&criteria= (accessed 6 June 2011).
19. Jack R The NATAVUS Study: necessity and technical adequacy of vascular ultrasound scans (MPhil Thesis). Brisbane: The University of Queensland ; 2010:
20. Beckman JA, Higgins CO, Gerhard-Herman M. Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice. Hypertension. 2006 ; 47: 35-38